Humoral Immune Response to Polymorphic Epithelial Mucin (MUC-1) in Patients with Benign and Malignant Breast Tumours

By von Mensdorff-Pouilly S.   Gourevitch M.M.   Kenemans P.   Verstraeten A.A.   Litvinov S.V.   van Kamp G.J.   Meijer S.   Vermorken J.   Hilgers J.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1325-1331

Elsevier

Access to resources Recommend Favorite

Elevated Luteinizing Hormone in Serum, Breast Cancer Tissue, and Normal Breast Tissue from Breast Cancer Patients

By Silva E.G.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 125-130

Springer Publishing Company

Access to resources Recommend Favorite

Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR

By Berois N.   Varangot M.   Aizen B.   Estrugo R.   Zarantonelli L.   Fernandez P.   Krygier G.   Simonet F.   Barrios E.   Muse I.   Osinaga E.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 717-723

Elsevier

Access to resources Recommend Favorite

O -glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model

By Premaratne Pushpa  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 203-213

Springer Publishing Company

Access to resources Recommend Favorite

MUC1 expression in primary breast cancer: the effect of tamoxifen treatment

By Hanson J.M.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite